miss expect set
thought reason low bar unfortun result
slightli miss consensu said preview thought might
risk buyer might want wait first half fiscal year
thought investor might model bump gone well
higher number could hard hit slightli slower cardiac end market
nervou investor might get ahead
expect miss surpris frankli got previou upgrad wrong
would rather admit stubborn maintain buy rate
feel appropri share price year base mo
revenu estim ep forecast thu rate move neutral
significantli slow growth stir debat abmd end market
difficult defin size high-risk pci shock market know
one point time iabp use pci
number use shock also know mani patient sick
get pci balloon may impella also may patient
shock doctor believ impella work balloon would
mani extra patient two bucket pci like much larger
imposs know past discuss view
market especi pci may smaller compani model
market still larg
significantli slow growth caus mani investor wonder
market especi pci smaller compani believ
inde earli adopt one would expect growth slow
degre think acceler growth futur remov
view mind mani potenti investor
sure center slow manag said small fraction
center saw growth either flatten declin center grew normal
seem around bad outcom miscod bill
reason regardless larger issu past need find
center tri learn recent slow
valuat assum grow feel
similar compani trade revenu best class near
think fair use either month revenu estim
ep estim would get us hypothet pt thu
move neutral
idc btig estim compani document
million except per share amount
rate neutral believ stori mani posit robust cash high margin potenti
indic expans under-penetrated market high barrier entri howev recent miss difficult
understand suggest address market may slower previous estim account
slower growth lower forecast feel use multipl month sale estim
adj ep appropri would theoret get us pt move neutral insuffici
upsid btig provid price target neutral-r stock
key product impella
enabl doctor use
cathet deliv tini heart
pump patient femor
arteri heart impella
move oxygen blood
left ventricl heart
bodi organ reliev
diseas heart help stabil
patient increas blood flow
one rare medic
devic compani still grow
core product well
stabl procedur growth price
expans current tam
cut reimburs
compani report world-wide impella revenu higher forecast impella revenu
grow slowdown growth driven organiz chang extern nois focu
implement train program ou impella revenu improv y/i support adopt
switzerland franc germani higher patient util japan revenu japan improv y/i
spur patient util new site manag anticip full year japan contribut total
march receiv japanes reimburs approv impella cp
gross margin weaker forecast pressur attribut smart assist launch
geograph sale mix sg spend better model due invest commerci team
train overal ebit margin higher model mainli lower oper expens
sum non-gaap ep exclud one-tim invest gain excess tax benefit beat forecast
reflect shortfal view short-term pressur high-risk pci busi revis guidanc
trim revenu go forward model revenu growth vs previous
actualsbtig estimate varianceu impella sale trial impella sale revenu net incom bpssg spend bpsr spend bpsebit bpstax bpssourc btig estim compani non- ep remov unreal gain compani invest shockwav medic rate etb varianc
addit commerci team on-going invest tweak oper margin forecast
move ep non- ep ex-on time gain stock compens
benefit previous
also trim y/i revenu growth assumpt accordingli know
market return growth futur assum oper leverag improv translat
healthi oper margin expans
rate neutral believ stori mani posit robust cash high margin potenti
indic expans under-penetrated market high barrier entri howev recent miss difficult
understand suggest address market may grow slowli previous estim account
slower growth lower forecast feel use multipl month sale estim
adj ep appropri would theoret get us pt move neutral insuffici
upsid btig provid price target neutral-r stock risk rate includ rebound protect pci
volum reimburs cut slippag product timelin chang procedur patent litig unsuccess data
fda
exhibit comp tabl fast-grow med-tech compani
impella sale impella sale net incom ep btig estim compani adjust ep exclud benefit shockwav rate excess tax benefit changentm inc ingnnot technologiesirtcbuy factset data btig estimatesintra-day ex-amortev/salescagrcompanytickerr ptpricemarket cap
abiom incom product fund total y/i good gross sg amort intangibles- total oper incom loss invest incom incom incom expens pre-tax incom incom gaap net incom gaap share non-gaap non-gaap non-gaap ex select calendar loss net product product product oper ep btig estim compani report
abiom revenu commercialnew impella unit asp stock impella cp cp unit cp asp cp stock impella unit asp stock impella rp rp unit rp asp rp stock stock y/i consol instal rate new growth impella impella product trial impella impella product product y/i product btig estim compani report
btig cover compani mention report
appendix analyst certif import disclosur
